Gufic Biosciences share news, announcements and annual reports
NSE: GUFICBIOBSE: 509079Pharmaceuticals & BiotechnologySmall Cap
Gufic Biosciences Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1985 on BSE, Oct 2004 on NSE
Last close ₹418.80down ₹4.95 (1.17%)BSE ₹420.40
Share price at the NSE close on 29 Oct 2026. Previous close ₹423.75.
29 Oct: open ₹423.00, high ₹424.05, low ₹416.25
52-week range of traded prices to 29 Oct 2026
₹268.00Low, 9 Mar 2026₹467.80High, 7 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,200 Cr959th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 57.17
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.32
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.02%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 11.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.58
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 26,73756.8% delivered
Gufic Biosciences share news and announcements
608 announcements, routine notices left out, newest first. Page 11 of 13.
Feb 2014
17 Feb · Results
14 Feb · Board Meeting Adjourned
As scheduled the Board of Directors met to discuss amongst other things, to consider and if thought fit to approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2013. The Board of Directors decided to adjourn the said meeting held on February 14, 2014 and further discussion and analysis and to decide on the matters on the agenda for next day morning.5 Feb · Board meeting
Amongst other things, to consider and take on record Unaudited Financial Results of the Company for the quarter ended December 31, 2013.
Dec 2013
23 Dec · Meeting
Nov 2013
15 Nov · Results
14 Nov · Board meeting
As scheduled the Board of Directors at it meeting held on November 14, 2013 met to discuss, amongst other things, to consider and if thought fit to approve the Unaudited financial Results of the Company for the quarter ended September 30, 2013. The Board of Directors decided to adjourn the said meeting and further discussion and analysis and to decide on the matters on the agenda on November 15, 2013.1 Nov · Board meeting
Amongst other things, to consider and take on record Unaudited Financial Results of the Company for the quarter ended 30th September, 2013.1 Nov · Address Change
Registered office of the Company is shifted from 2nd Floor, Building A, Moti Baug, 118/119, S. V. Road, Andheri West, Mumbai - 400058 to Shop - 37, First Floor, Kamala Bhavan II, Swami Nityanand Road, Andheri East, Mumbai - 400069 with effect from October 05, 2013.
Oct 2013
7 Oct · Board meeting
Among other things, change of registered office within local limits
Sep 2013
2 Sep · Corporate action
Gufic Biosciences Limited had informed the Exchange that the Company has decided to close Books from September 4, 2013 to September 7, 2013 (both days inclusive) for the purpose of Annual General Meeting of the Company to be held on September 7, 2013 & payment of dividend, if sanctioned by the shareholders in their meeting. The Company has now informed the Exchange that Annual General Meeting of the Members of the Company has been postponed from September 07, 2013 to September 26, 2013. Further, Book Closure dates for payment of Dividend will be from September 23, 2013 to September 26, 2013 (both days inclusive).
Aug 2013
14 Aug · Meeting
Company has decided to close Books from September 4, 2013 to September 7, 2013 (both days inclusive) for the purpose of Annual General Meeting of the Company to be held on September 7, 2013 & payment of dividend, if sanctioned by the shareholders in their meeting.13 Aug · Management
Mr. Pankaj Gandhi and Mr. Jagdish Shah appointed as additional directors w.e.f. August 01, 20132 Aug · Board meeting
(1)To consider the Unaudited Financial Results of the Company for the quarter ended June 30, 2013 (2) Fix the date of Annual General Meeting & decide to close the Books of the Company for the purpose of Annual General Meeting such other items as the board may deem fit
Jun 2013
May 2013
31 May · Dividend
Board of Directors of the Company at their meeting held on May 30, 2013 has recommended dividend @5% per share (i.e.Rs.0.05 per share).22 May · Board meeting
Inter alia, to consider and if thought fit to approve the annual audited financial results of the Company for the year ended on March 31, 2013, to recommend dividend, if any, and any other item(s) with the permission of the chair.22 May · Board meeting Cancelled
Gufic Biosciences Limited had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on May 15,2013 Amongst other things, to consider and take on record Unaudited Financial Results of the Company for the quarter ended March 31, 2013.The Company has now informed the Exchange that the board of directors meeting scheduled to be held on May 15, 2013 has been cancelled.7 May · Board meeting
Amongst other things, to consider and take on record Unaudited Financial Results of the Company for the quarter ended March 31, 2013.
Feb 2013
6 Feb · Board meeting
To consider among other things, Unaudited Financial Results for the quarter ended December 31, 2012
Nov 2012
5 Nov · Updates
Fire had broken out in one of the API units at Navsari Factory on November 02, 2012 and it had been controlled. No casualties have occurred.
Oct 2012
31 Oct · Board meeting
To consider among other items, the Unaudited Financial Results for the quarter ended on September 30, 2012.3 Oct · Board meeting
Board of Directors of the Company at their meeting held on October 03, 2012 approved the following items : (1) The Registered office of the Company be shifted within the local limits of the city from Gufic House, Subhash Road A, Vile Parle East, Mumbai - 400 057 to 2nd Floor, Building A, Moti Baug, 118/119, S. V. Road, Andheri West, Mumbai - 400 058; (2) Conversion of Unsecured Loans in to Equity brought in by Jayesh P. Choksi, Chairman & Managing Director of the Company; (3) Such other items as the chairman of the meeting thought fit.
Sep 2012
25 Sep · Board meeting
Amongst other things, to shift the registered office of the Company within local limits.
Aug 2012
14 Aug · Results
6 Aug · Board meeting
Amongst other things, to consider and take on record Unaudited Financial Results of the Company for the quarter ended June 30, 2012.
Jul 2012
10 Jul · Meeting
Meeting of Board of Directors of the Company held on July 10, 2012 has approved the following business : (1) Fixed the Annual General Meeting to be held on August 24, 2012. (2) Decided to close the Books of the Company for the purpose of Annual General Meeting and, if sanctioned by the shareholders in their meeting, for payment of Dividend from August 20, 2012 to August 24, 2012 (both days inclusive).10 Jul · Dividend
Board of Directors of the Company at its meeting held on July 10, 2012 has recommended dividend @ 5% per share (i.e. Re. 0.05 per share).2 Jul · Board meeting
Amongst other things, to consider and if thought fit to recommend dividend for the year ended on March 31, 2012.
Jun 2012
15 Jun · Results
6 Jun · Board meeting
Amongst other things, to consider and if thought fit to approve the Annual Accounts of the Company for the year ended on March 31, 2012. At the same time also to consider and if thought fit to recommend dividend.
May 2012
16 May · Results
9 May · Board meeting
Amongst other things, to consider and take on record Unaudited Financial Results of the Company for the quarter ended March 31, 2012.
Feb 2012
Dec 2011
8 Dec · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended September 30,2011. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2011
4 Nov · Board meeting
Amongst other things, to consider and take on record Unaudited Financial Results of the Company for the quarter ended September 30, 2011.
Sep 2011
2 Sep · Meeting
Meeting of Board of Directors of the Company was held on August 30, 2011 and following decisions are taken : (1) Fixed the Annual General Meeting to be held on September 26, 2011.(2) Decided to close the Books of the Company for the purpose of Annual General Meeting and, if sanctioned by the shareholders in their meeting, for payment of Dividend from September 20, 2011 to September 26, 2011 (both days inclusive). (3) Decided to pay the dividend, if sanctioned by the shareholders in their meeting, before October 26, 2011.2 Sep · Dividend
Board of Directors of the Company at its meeting held on August 30, 2011 has decided to declare dividend @ 5% per share (i.e. Re.0.05 per share) subject to shareholders approved at the Annual General Meeting.
Aug 2011
27 Aug · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2011. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Aug · Board meeting
Amongst other things, to consider and if thought fit to approve the Annual Accounts of the Company for the year ended on March 31, 2011. At the same time also to consider and if thought fit to recommend dividend.16 Aug · Results
2 Aug · Board meeting
Amongst other things, to consider and take on record unaudited Financial Results of the company for the quarter ended June 30, 2011.
May 2011
17 May · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended March 31,2011. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.